TTM
$4.92B
YoY change
+9.7%
5Y CAGR
+7.6%
Peak year (2025)
$4.74B
Cumulative gross profit
$51.58B
Gross Profit history chart for Edwards Lifesciences (EW) from 1999 to 2025
Latest: $4.74B
Gross Profit growth chart for Edwards Lifesciences (EW) from 1999 to 2025
Latest: +9.7%
Gross Profit history table for Edwards Lifesciences (EW) from 1999 to 2025
| 2025 | $4.74B | +9.7% | +$418.70M | ||
| 2024 | $4.32B | +8.8% | +$349.30M | ||
| 2023 | $3.97B | -5.8% | −$242.50M | ||
| 2022 | $4.22B | +5.2% | +$208.60M | ||
| 2021 | $4.01B | +21.9% | +$719.30M | ||
| 2020 | $3.29B | +3.0% | +$94.60M | ||
| 2019 | $3.19B | +14.0% | +$392.00M | ||
| 2018 | $2.80B | +9.7% | +$248.30M | ||
| 2017 | $2.55B | +18.3% | +$394.50M | ||
| 2016 | $2.16B | +19.3% | +$348.50M | ||
| 2015 | $1.81B | +7.0% | +$117.70M | ||
| 2014 | $1.69B | +12.7% | +$190.10M | ||
| 2013 | $1.50B | +7.8% | +$108.80M | ||
| 2012 | $1.39B | +14.4% | +$175.00M | ||
| 2011 | $1.22B | +17.4% | +$180.90M | ||
| 2010 | $1.04B | +13.0% | +$119.60M | ||
| 2009 | $917.30M | +10.7% | +$88.50M | ||
| 2008 | $828.80M | +16.8% | +$119.00M | ||
| 2007 | $709.80M | +8.6% | +$56.10M | ||
| 2006 | $653.70M | +4.9% | +$30.40M | ||
| 2005 | $623.30M | +11.0% | +$62.00M | ||
| 2004 | $561.30M | +12.0% | +$60.20M | ||
| 2003 | $501.10M | +23.8% | +$96.20M | ||
| 2002 | $404.90M | +10.0% | +$36.90M | ||
| 2001 | $368.00M | -3.4% | −$13.00M | ||
| 2000 | $381.00M | -13.2% | −$58.00M | ||
| 1999 | $439.00M | — | — |
- 2025$4.74B+9.7%
- 2024$4.32B+8.8%
- 2023$3.97B-5.8%
- 2022$4.22B+5.2%
- 2021$4.01B+21.9%
- 2020$3.29B+3.0%
- 2019$3.19B+14.0%
- 2018$2.80B+9.7%
- 2017$2.55B+18.3%
- 2016$2.16B+19.3%
- 2015$1.81B+7.0%
- 2014$1.69B+12.7%
- 2013$1.50B+7.8%
- 2012$1.39B+14.4%
- 2011$1.22B+17.4%
- 2010$1.04B+13.0%
- 2009$917.30M+10.7%
- 2008$828.80M+16.8%
- 2007$709.80M+8.6%
- 2006$653.70M+4.9%
- 2005$623.30M+11.0%
- 2004$561.30M+12.0%
- 2003$501.10M+23.8%
- 2002$404.90M+10.0%
- 2001$368.00M-3.4%
- 2000$381.00M-13.2%
- 1999$439.00M—
Gross Profit values are taken from Edwards Lifesciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's current gross profit (TTM) is $4.92B. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Edwards Lifesciences (EW) most recent annual gross profit stands at $4.74B (2025) – grew 9.7% year-over-year.
Across 2020–2025 (5 years), Edwards Lifesciences gross profit produced a CAGR of +7.6% – sustaining 2 straight years of year-over-year growth.
$4.74B stands as the all-time-high annual gross profit, posted in 2025, against a low of $368.00M during 2001.
Edwards Lifesciences Gross Profit by Year
Edwards Lifesciences Gross Profit 2025: $4.74B
In 2025, Edwards Lifesciences reported gross profit of $4.74B, grew 9.7% from 2024. This figure represents the highest annual value in the available history.
Edwards Lifesciences Gross Profit 2024: $4.32B
Edwards Lifesciences gross profit in 2024 was $4.32B, grew 8.8% from 2023.
Edwards Lifesciences Gross Profit 2023: $3.97B
2023's gross profit for Edwards Lifesciences came in at $3.97B, declined 5.8% below 2022.
Edwards Lifesciences Gross Profit 2022: $4.22B
Edwards Lifesciences posted gross profit of $4.22B in 2022, grew 5.2% from 2021.
Edwards Lifesciences Gross Profit 2021: $4.01B
Edwards Lifesciences gross profit in 2021 was $4.01B.
See more financial history for Edwards Lifesciences (EW).
Sector peers by Gross Profit
Healthcare peers of Edwards Lifesciences (EW), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation